Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × eliglustat × Clear all

NCT04944888 2023-12-19

GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms